Flerie Invest logo

Flerie Invest

Europe, Stockholms Lan, Sweden, Stockholm

Description

Flerie Invest is a Europian investment firm that makes investments in the health care sector companies.

Investor Profile

Flerie Invest has made 25 investments, with 3 in the past 12 months and 52% as lead.

Stage Focus

  • Series A (36%)
  • Series Unknown (28%)
  • Series B (20%)
  • Seed (8%)
  • Series D (4%)
  • Post Ipo Equity (4%)

Country Focus

  • Sweden (32%)
  • United Kingdom (20%)
  • The Netherlands (16%)
  • Israel (16%)
  • United States (12%)
  • Iceland (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Oncology
  • Health Diagnostics
  • Genetics
  • Biopharma
  • Child Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Flerie Invest frequently co-invest with?

Thuja Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 3
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
British Patient Capital
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 2
IP Group
Europe, England, United Kingdom, London
Co-Investments: 2
HBL Hadasit Bio Holdings
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 2

Which angels does Flerie Invest often collaborate with?

MV
Europe, Madrid, Spain, Madrid
Shared Deals: 1
Shared Deals: 1
PB
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Flerie Invest?

AnaCardio

Solna, Stockholms Lan, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

BiopharmaBiotechnologyMedical
Series AJan 9, 2025
Amount Raised: $18,379,535
Vitara Biomedical

Philadelphia, Pennsylvania, United States

Vitara Biomedical develops a therapeutic platform to support premature infants.

Child CareHealth CareHealth DiagnosticsMedical Device
Series BNov 18, 2024
Amount Raised: $50,000,000
Microbiotica

Cambridge, Cambridgeshire, United Kingdom

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 27, 2024
Synerkine Pharma

Utrecht, Utrecht, The Netherlands

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

BiotechnologyHealth Care
Series AOct 12, 2023
Amount Raised: $5,584,067
LipUm

Umeå, Vasterbottens Lan, Sweden

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquitySep 22, 2022
Amount Raised: $3,523,282
Vitara Biomedical

Philadelphia, Pennsylvania, United States

Vitara Biomedical develops a therapeutic platform to support premature infants.

Child CareHealth CareHealth DiagnosticsMedical Device
Series BSep 13, 2022
Amount Raised: $75,000,000
AnaCardio

Solna, Stockholms Lan, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

BiopharmaBiotechnologyMedical
Series ASep 7, 2022
Amount Raised: $14,012,919
XNK Therapeutics

Huddinge, Stockholms Lan, Sweden

XNK Therapeutics is a clinical stage, immunotherapy company.

PharmaceuticalTherapeutics
Series UnknownMar 29, 2022
Amount Raised: $14,153,788
Geneos Therapeutics

Plymouth Meeting, Pennsylvania, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AMar 24, 2022
Amount Raised: $17,000,000
Strike Pharma

Uppsala, Uppsala Lan, Sweden

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).

BiotechnologyPharmaceuticalPrecision MedicineTherapeutics
Series UnknownFeb 22, 2022
Amount Raised: $4,821,997